Yang, W., Hosford, S. R., Dillon, L. M., Shee, K., Liu, S. C., Bean, J. R., . . . Miller, T. W. (2016). Strategically timing inhibition of phosphatidylinositol 3-kinase to maximize therapeutic index in estrogen receptor alpha-positive, PIK3CA-mutant breast cancer. Clin Cancer Res.
Citação norma ChicagoYang, Wei, et al. "Strategically Timing Inhibition of Phosphatidylinositol 3-kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-positive, PIK3CA-mutant Breast Cancer." Clin Cancer Res 2016.
Citação norma MLAYang, Wei, et al. "Strategically Timing Inhibition of Phosphatidylinositol 3-kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-positive, PIK3CA-mutant Breast Cancer." Clin Cancer Res 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.